NCT05702684

Brief Summary

The overarching aim is to study the coproduction of personalised care in a digital age by seeking to improve the experience of care and personalised care and support planning for people who live with and beyond colorectal cancer. This study will assess digital health contributions to personalised care and explore how to improve the quality of collaborative digital care planning in cancer services. The electronic holistic needs assessment (eHNA) developed by Macmillan Cancer Support (macmillan.org.uk/healthcare-professionals/innovation-in-cancer-care/holistic-needs-assessment/sign-up-to-ehna) will be used as a case study to help advance this aspect of healthcare improvement studies. The primary objective is to gain a better understanding of how personalised care and support planning in the form of the eHNA and consultation works (or not) from the perspectives of people who are living with and beyond colorectal cancer, and clinicians. The secondary objectives are to: i. identify what good practice looks like for digital personalised care and support planning in a specific tumour group (colorectal) and at a point in the cancer pathway (within 31 days of diagnosis) ii. explore if the ARC framework can be used to inform personalised cancer care and support planning The research will review current practice and focus on identifying what good looks like for digital cancer care planning. It will go on to explore how what we know about LWBC can be used to inform the co-design of digital care planning that better supports personalised long-term cancer care. From the outset, this early work will help to inform future issues around generalisability and scaling-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 9, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 27, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

July 31, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2025

Completed
Last Updated

February 12, 2026

Status Verified

December 1, 2025

Enrollment Period

2.4 years

First QC Date

January 9, 2023

Last Update Submit

February 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient experience

    Improved experience of care as measured through video-reflexive ethnography processes

    Through study completion up to 12 months

Study Arms (2)

People living with colorectal cancer

Patients (who are living with colorectal cancer) who have agreed to complete the eHNA intervention (within 31 days of diagnosis) and care planning consultation and clinicians who work in cancer services and provide the eHNA intervention to patients who are living with colorectal cancer

Other: electronic Holistic Needs Assessment (eHNA)

People living with treatable-but-not-curable cancer

Patients who have received the ARC Holistic Needs Assessment (HNA) intervention from the ARC clinic and clinicians responsible for developing/delivering the ARC HNA intervention.

Other: electronic Holistic Needs Assessment (eHNA)

Interventions

eHNA to be completed within 31 days of diagnosis (standard care). ARC clinic previously offered 6-24 months post-diagnosis.

Also known as: ARC clinic
People living with colorectal cancerPeople living with treatable-but-not-curable cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will focus on colorectal (including metastatic disease but not end of life) cancer. This group of patients have immediate needs (i.e., body image, disruption in life), and require ongoing treatment (up to 15 years of treatment options). This tumour group also has a fairly equal age and gender distribution and is underrepresented in research (Sun et al., 2021). Changes to colorectal cancer care delivery during the COVID-19 pandemic have also shown to increase healthcare inequalities (Ip et al., 2022). The study will focus on the eHNA process at diagnosis (within 31 days of diagnosis) because this is already a focus for services in terms of meeting NHS England key performance indicators.

You may qualify if:

  • Patients
  • Patients (who are living with and beyond colorectal cancer) who have agreed to complete the eHNA intervention within 31 days of diagnosis OR patients who received the ARC clinic HNA intervention.
  • Over 18 years of age
  • Speak a conversational level of English Patients will be sampled purposively to ensure a range of experiences. Patients will be sampled on ethnicity, gender, age, time since diagnosis, socio-economic status, and digital maturity, so that findings can also be used to explore and address cancer inequalities.
  • Paired clinicians
  • Clinicians (e.g., CNS, AHP, cancer support worker) who work in cancer services and provide the eHNA/ARC intervention to (the recruited) patients who are living with colorectal cancer.
  • Over the age of 18
  • Speak a conversational level of English.
  • Team members
  • Clinicians (e.g., CNS, AHP, cancer support worker) who work in the colorectal cancer team or who work in close liaison with the colorectal cancer team and are responsible for providing the eHNA and care planning consultation.
  • Over the age of 18
  • Speak a conversational level of English.

You may not qualify if:

  • Patients
  • Patients (who are living with and beyond cancer) who are receiving treatment but who have not agreed to complete an eHNA /patients who did not attend the ARC clinic.
  • Under 18 years of age
  • Do not speak a conversational level of English
  • Patients who lack capacity to consent
  • Paired Clinicians 1. Clinicians who do not provide the eHNA intervention /ARC intervention to patients who are living with and beyond cancer.
  • Team members
  • \. Clinicians (e.g., CNS, AHP, cancer support worker) who do not work in the colorectal cancer team or in close liaison with the colorectal cancer team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guy's & St Thomas' NHS Foundation Trust

London, United Kingdom

Location

Related Publications (5)

  • Carroll K, Mesman J. Multiple Researcher Roles in Video-Reflexive Ethnography. Qual Health Res. 2018 Jun;28(7):1145-1156. doi: 10.1177/1049732318759490. Epub 2018 Feb 24.

    PMID: 29478407BACKGROUND
  • Wyer M, Jackson D, Iedema R, Hor SY, Gilbert GL, Jorm C, Hooker C, O'Sullivan MV, Carroll K. Involving patients in understanding hospital infection control using visual methods. J Clin Nurs. 2015 Jun;24(11-12):1718-29. doi: 10.1111/jocn.12779. Epub 2015 Feb 7.

    PMID: 25662176BACKGROUND
  • Iedema R. Research paradigm that tackles the complexity of in situ care: video reflexivity. BMJ Qual Saf. 2019 Feb;28(2):89-90. doi: 10.1136/bmjqs-2018-008778. Epub 2018 Oct 11. No abstract available.

    PMID: 30309911BACKGROUND
  • Varpio L, Ajjawi R, Monrouxe LV, O'Brien BC, Rees CE. Shedding the cobra effect: problematising thematic emergence, triangulation, saturation and member checking. Med Educ. 2017 Jan;51(1):40-50. doi: 10.1111/medu.13124.

    PMID: 27981658BACKGROUND
  • Iedema RA, Angell B. What are patients' care experience priorities? BMJ Qual Saf. 2015 Jun;24(6):356-9. doi: 10.1136/bmjqs-2015-004298. Epub 2015 May 13. No abstract available.

    PMID: 25972222BACKGROUND

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Clair Le Boutillier

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2023

First Posted

January 27, 2023

Study Start

July 31, 2023

Primary Completion

December 12, 2025

Study Completion

December 12, 2025

Last Updated

February 12, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

The study is compliant with the requirements of General Data Protection Regulation (2016/679) and the Data Protection Act (2018). All investigators and study site staff will comply with the requirements of the General Data Protection Regulation (2016/679) with regards to the collection, storage, processing, and disclosure of personal information, and will uphold the Act's core principles. The sponsors for this study will be King's College London (KCL) and Guys and St Thomas' NHS Foundation Trust (GSTT). KCL and GSTT are joint data controllers.

Locations